Literature DB >> 6986176

Increased in vitro B-cell IgG secretion during acute graft-versus-host disease and infection. Observations in 50 human marrow transplant recipients.

O Ringden, R P Witherspoon, R Storb, E Ekelund, E D Thomas.   

Abstract

B-cell antibody secretion by lymphocytes from 50 bone marrow transplant recipients and 42 healthy controls was studied in vitro using an indirect hemolysis-in-gel assay to determine Ig-class-specific plaque-forming cells (PFC). The numbers of PFC were determined in medium alone and after stimulation of lymphocytes with killed Staphylococcus aureus bacteria. The PFC responses for IgG, IgA, and IgM after stimulation with S. aureus were significantly lower in patients studied during the first 101 days after grafting compared to normals. Statistically significant increased IgG-PFC were found in patients who had acute graft-vesus-host disease (GVHD), grafts from HLA-nonidentical donors, or infections. Healthy patients studied more than 1 yr following transplantation had normal B-cell responses, but patients with chronic GVHD had deficient IgM production. The data suggest that antibody secretion by B cells varies in different marrow transplant patient subgroups and present a basis for further investigation of the interaction between lymphocyte subpopulations leading to antibody production.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986176

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Characterization of plasma cell populations at autopsy after human allogeneic bone marrow transplantation.

Authors:  S Cousineau; R Belanger; C Perreault
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

3.  B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes.

Authors:  J H Antin; K A Ault; J M Rappeport; B R Smith
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Functional and morphological suppressor T cell deficit in acute GVHD.

Authors:  F Di Padova; A Gratwohl; M Corneo; B Speck
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

5.  GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.

Authors:  Min-Jung Park; Seung Hoon Lee; Sung-Hee Lee; Eun-Kyung Kim; Eun Jung Lee; Young-Mee Moon; Mi- La Cho
Journal:  J Transl Med       Date:  2016-07-08       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.